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 Background: Although originally described as a survival mechanism, it is unknown whether and to what extent autophagy 
is implicated in the terminal stages of heart failure. Here, we studied magnitude and evolution of autophagy 
in patients with intractable heart failure.
 Material/Methods: Myocardial samples were obtained from 22 patients with ischemic cardiomyopathy and idiopathic dilated car-
diomyopathy who were undergoing cardiac transplantation. Hearts from 11 patients who died from non-car-
diac causes were used as control samples. Autophagy was evaluated by immunostaining with a monoclonal 
microtubule associated protein light chain 3 (LC3)-II antibody, while the relationship of autophagy with apop-
tosis and oncosis was assessed by double staining with TUNEL (terminal deoxynucleotidyl transferase – me-
diated deoxyuridine triphosphate nick end labeling) assay and complement 9 (C9) immunological staining, re-
spectively. In addition, several necroptotic markers, including RIP1 and RIP3 (receptor interacting protein kinase 
1 and 3), anti-C3 (cleaved-caspase-3), and anti-NF-kB (nuclear factor kappa-light-chain-enhancer of activated 
B cells) were assessed by immunohistochemistry.
 Results: Anti-LC3-II staining was detected in 8.7±1.6% of the heart failure patient heart samples and in 1.2±0.3% of 
control patient heart samples. Vacuole formation started at one nuclear pole, before becoming bipolar and in-
volving the cytosol. Subsequently, the autophagic process extended also to the nuclei, which underwent a pro-
gressive vacuolization and disintegration, assuming a peculiar “strawberry like appearance”. Myocytes with 
extensive vacuole formation exhibited nuclear degeneration, which was associated with TUNEL, C3, C9, RIP1, 
and RIP3 positive staining. Conversely, myocytes with less extensive vacuole formation showed RIP1 and NF-kB 
positive staining, though not positivity for other cell death markers.
 Conclusions: Autophagy was extensively detected in end-stage heart failure and its progression, resulted in secondary cell 
death, with occurrence of oncosis and necroptosis exceeding that of apoptosis. Conversely, activation of the 
RIP1/NF-kB pathway was associated with cell survival.
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Background
Myocyte cell loss is an important mechanism in the develop-
ment of heart failure. Although the traditional explanation for 
myocytes cell loss has been accidental cell death, lately there 
has been a surge of evidence affirming the role of apoptotic 
cell death [1]. More recently, other causes of cell loss have been 
reported. Indeed, besides necrosis and apoptosis, autophagy 
has also been reported to occur in cardiac myocytes [2] and 
has been recognized to play a role in the pathophysiology of 
human heart failure [3–5], as well as in ischemia-reperfusion 
injury [6,7]. Notably, recent findings have suggested that the 
occurrence of autophagy enhanced the survival of cardiac cells 
in hearts exposed to permanent coronary artery occlusion [6].
Macroautophagy (hereafter referred to as autophagy) is a pro-
cess of intracellular bulk degradation in which cytoplasmic com-
ponents, including organelles, are sequestered within double-
membrane vesicles (autophagosomes) and finally delivered to 
the lysosome for degradation [8,9]. Autophagy has long been 
known to be a physiological mechanism of cell survival during 
periods of temporary starvation, and has, for example, been ob-
served in mice between birth and suckling [10]. As such, it may 
also occur during brief periods of ischemia [11]. Indeed, autopha-
gosomes and autophagy have been observed in rabbit hearts 
exposed to 20 to 40 minutes of simulated ischemia followed 
by reperfusion [12], and this was associated with recovery of 
myocyte function. Surprisingly, except for isolated reports [13], 
the subsequent literature has paid little attention to autophagy 
as a cell protective mechanism in the ischemic myocardium.
Despite the most recent advances in understanding the molec-
ular mechanisms and biological functions of autophagy [11], 
it is currently uncertain whether autophagy acts primarily as 
a cell survival mechanism versus a cell death pathway or both 
under different conditions. In the case of a shortage of intra-
cellular nutrients secondary to starvation/growth factor with-
drawal or impaired adenosine triphosphate (ATP) synthesis in 
the setting of ischemia, autophagy may help promote cell sur-
vival, either by purging the cell of damaged organelles, or by 
generating the intracellular building blocks required to main-
tain vital functions, which finally results in ATP production, mac-
romolecular synthesis, and improved cell survival [14]. Under 
more extreme conditions, autophagy may also promote cell 
death through excessive self-digestion and degradation of es-
sential cellular constituents. There are 16 proteins participat-
ing in the autophagy pathway in man. The autophagy light-
chain-3 protein (LC3), a mammalian homologue of Atg8, was 
originally identified as microtubule-associated protein [15]. 
LC3 is the only known mammalian protein, which stably as-
sociates with the autophagosome membranes and is com-
monly used as a sensitive marker for detecting autophagy in 
mammalian cells. Although originally described as a survival 
pathway against stressful events, whether and to what ex-
tent autophagy is implicated in the terminal stages of heart 
failure is unknown.
Accidental cell death with swelling, namely oncosis, is the main 
type of cell demise documented in known models of ischemic 
injury [16]. Complement 9 (C9), a part of the membrane at-
tacking complex C5b-9, is a member of the complement mem-
brane attack complex (MAC) that forms transmembrane chan-
nels. These channels disrupt the cell membrane of target cells, 
leading to cell lysis and death [17]. For this reason, C9 is con-
sidered a useful tool for detection of early oncosis [18].
Necroptosis is a well-characterized cell damaging process, 
combining morphological features of accidental cell death and 
maladaptive autophagy. Indeed, necroptosis involves loss of 
membrane integrity and release of damage-associated mo-
lecular pattern molecules (DAMPs), resulting in secondary in-
flammatory response [19]. Biochemically, necroptosis is a pro-
grammed process orchestrated by a complex set of proteins 
involving receptor-interacting protein kinase 1 and 3 (RIP1, 
RIP3), as well as mixed lineage kinase domain-like protein 
(MLKL). Activation of the RIP1-RIP3-MLKL signaling pathway 
leads to disruption of cation homeostasis, plasma membrane 
rupture, and finally cell death [20].
Nuclear factor kappa-light-chain-enhancer of activated B cells 
(NF-kB) is a redox-regulated transcription factor involved in in-
flammation, immune function, cellular proliferation [21], apop-
tosis [22], and anti-apoptotic activities [23]. The nature of the 
signals elicited by death inducers determines whether NF-kB 
induction leads to apoptosis or survival [24].
Because heart failure patients commonly have high levels 
of inflammation [25], we hypothesized that cardiomyocytes 
could be damaged primarily by autophagy and/or oncosis/
necroptosis rather than apoptosis. Hence, the aim of the pres-
ent study was to evaluate the magnitude and progression of 
autophagy and the simultaneous presence of oncosis/necrop-
tosis and apoptosis in patients with intractable heart failure 
by immunohistochemistry (IHC) using anti-LC3-II, anti-C9, anti-
RIP1, anti-RIP3, anti-NF-kB, TUNEL (terminal deoxynucleotidyl 
transferase–mediated deoxyuridine triphosphate nick end la-
beling), and anti-C3 (cleaved caspase-3) antibodies, and elec-
tron microscopy (EM) morphology.
Material and Methods
Patient population
The work has been carried out in accordance with The Ethics 
Code of the World Medical Association (Declaration of Helsinki). 
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The study was approved by the Institutional Review Board of 
the University of Verona and all patients selected gave in-
formed consent prior to enrollment.
Myocardial samples were obtained from the hearts of 22 pa-
tients (7 female and 15 male) with ischemic cardiomyopathy 
(n=10) and idiopathic dilated cardiomyopathy (n=12) who 
underwent cardiac transplantation (Table 1). Among the pa-
tients with ischemic cardiomyopathy, 6 had a previous myo-
cardial infarction and 7 underwent surgical revascularization.
All patients were medically treated with angiotensin converting 
enzyme (ACE) inhibitors, b-blockers, potassium sparing agents, 
and diuretics at maximal doses before transplantation. All pa-
tients had also received short-term intermittent treatment with 
intravenous inotropic agents at different stages.
All hearts were harvested in the surgical setting of cardiac 
transplantation and never post-mortem. The control hearts 
were collected from 11 patients (5 females and 6 males), who 
died from non-cardiac causes; control hearts were collected 
1 hour to 6 hours after patient’s death (Table 2).
Hemodynamic evaluation
Anatomical and functional properties of the failing hearts 
were measured by 2-dimensional echocardiography at 1 to 3 
months before transplantation. Pressure measurements were 
determined by cardiac catheterization.
Tissue sampling and preparation
At the time of transplantation, tissue was removed from the 
left ventricular free wall and parceled into 3 portions. The first 
Variable Female (n=7) Male (n=15) Normal value
Idiopathic dilated cardiomyopathy 4 8 n.a.
Ischemic cardiomyopathy 3 7 n.a.
Age (years) 58.31±4.1 55.48±3.2 n.a.
Heart weight (grams) 368±121 455±114 275–330
Left ventricular systolic diameter (mm) 59±5 60±8 20–36
Left ventricular diastolic diameter (mm) 68±4 72±8 37–56
Wall thickness/chamber diameter 0.26±0.06 0.23±0.07 0.32–0.39
Ejection fraction (%) 20±5 22±6 >50
Cardiac output (mL/min) 3923±1284 4132±1059 5000–7000
Cardiac index (mL×min–1×(m2)–1) 2375±689 2312±458 2600–4200
Pulmonary artery wedge pressure (mmHg) 19±3 22±4 1–10
Right ventricular end-diastolic pressure (mmHg) 12±9 13±7 0–8
Duration of disease (months) 121±26 74±17 n.a.
Onset of disease to heart failure (months) 91±53 65±32 n.a.
Time from heart failure to transplantation (months) 26±15 18±21 n.a.
Table 1. Demographical, clinical, anatomical, and functional characteristics of heart failure patients.
Variable Female (n=5) Male (n=6) Normal value
Car accident resulting in head injury 3 4 n.a.
Ischemic stroke 2 1 n.a.
Aortic dissection 0 1 n.a.
Age (years) 48.54±3.9 51.23±2.8 n.a.
Heart weight (grams) 287±24 312±33 275–330
Table 2. Demographical and clinical characteristics of control patients.
Results are presented as mean ± standard deviation. n.a. – not applicable.
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fragment part was fixed in 4% formaldehyde, stored at 4°C 
for a maximum of 48 hours, subsequently wax-embedded and 
finally used for immunofluorescent (IF), IHC, or hematoxylin 
and eosin (H and E) staining. The second fragment was col-
lected into cryovials, snap-frozen in liquid nitrogen, stored at 
–80°C, and finally used for protein isolation from total tissue 
extracts. The third and last fragment was immediately fixed in 
buffered glutaraldehyde for electron microscopy.
Immunoblotting
Heart specimens were homogenized in lysis buffer (100 mmol/L 
NaCl, 0.1% Triton X-100, 50 mmol/L Tris; pH 8.3) loaded on 
8% SDS-polyacrylamide gel, separated by gel electrophoresis, 
transferred onto a nitrocellulose membrane and probed with 
a relevant primary antibody.
Types and sources of the antibody used for the immunoblot-
ting procedure are as follows: the antibody against a-actin 
(sc-32251), LC3-I (sc-134226), and LC3-II (sc-271625) were ob-
tained from Santa Cruz Biotechnology (Santa Cruz, CA, USA). 
Secondary antibodies were conjugated to horseradish per-
oxidase and the ensuing immunoreactive bands were devel-
oped using a Western Lightning Chemiluminescence (WLC) kit 
(PerkinElmer Life Science, MA, USA). The nitrocellulose mem-
brane used for western blotting was obtained from Bio-Rad 
Laboratories (Hercules, CA, USA). Immunoblots were digitalized 
and quantified using NIH ImageJ software (National Institute 
of Health, Bethesda, MD, USA).
Immunohistochemistry (IHC)
Autophagy was evaluated by immunostaining with a monoclonal 
antibody against LC3-II (sc-271625), while its relationship with 
apoptosis and necrosis was assessed by double-staining with a 
TUNEL assay kit (In Situ Cell Death Detection Kit, Roche Applied 
Science, IN, USA) and anti-C9 immune-staining (ab168345, from 
Abcam, Cambridge, MA, USA), respectively, used as a convenient 
tool for the detection of early oncosis in failing hearts [18,26,27]. 
Serial 5 µm myocardial sections were serially cut from the same 
wax blocks, stained with an LC3-II antibody, TUNEL reagents, 
or a C9 antibody according to manufacturer instructions, and 
subsequently incubated with appropriate fluorescent secondary 
antibodies (Dako Cytomation, Glostrup, Denmark), and finally 
counterstained with propidium iodide. To avoid autofluores-
cence of lipofuscin, the sections were stained with Sudan black 
before observation at confocal microscope. The percentage 
of co-localization of LC3-II positive staining with TUNEL or C9 
positive labelling was digitally quantified by means of image 
analyzer software. Sections were analyzed by a confocal mi-
croscopist who was blinded to the origin and sequence of the 
specimens. Data were expressed as the means ± standard de-
viation (SD) of 12 to 15 high power fields.
In another set of experiments, sections were stained with anti-
C3 antibody (Novus Biologicals, NB100-56113) diluted 1: 100, 
anti-NF-kB antibody (NB110-57266) diluted 1: 250, RIP3 anti-
body (Gene-Tex, GTX-107574) diluted 1: 100, and anti-RIP1 anti-
body (sc-133102, Santa Cruz Biotechnology Inc.) diluted 1: 100. 
The sections were visualized with a rabbit ABC-peroxidase 
staining system kit (Santa Cruz Biotechnology Inc.). The IHC 
of controls was performed omitting the primary antibody. The 
ABC-peroxidase staining intensity in IHC was evaluated using 
Image Pro Plus 4.5.1 image analysis program. The optical den-
sity (OD) was calculated for arbitrary areas, by measuring 10 
fields for each sample.
On sections stained with anti-NF-kB, we also counted the per-
centage of immune stained nuclei. The number of anti-NF-kB 
stained nuclei present in 1 mm2 was determined on randomly 
chosen areas at 400x magnification. From these data and the 
area of the tissue section, positive nuclei were expressed as 
a % of the total number.
Electron microscopy
The heart samples were fixed with 3% glutaraldehyde in cac-
odylate buffer (pH 7.4, 0.2 M) and post-fixed with 1% osmium 
tetroxide as previously described [28]. The pH was adjusted 
to 7.4 and the osmolarity to 330 milliosmoles per liter to as-
sure dimensional stability of the specimens. Furthermore, the 
samples were processed with standard procedures for em-
bedding in Araldite (Sigma-Aldrich Chemical Co., Milan, Italy). 
Thick sections (about 1 µm) were stained with Epoxy Tissue 
Stain (#14950, Electron Microscopy Sciences, PA, USA). The ul-
trathin sections (70 nm) were double-stained with a saturated 
aqueous solution of uranyl acetate and lead citrate and exam-
ined with a Philips CM10 electron microscope (Royal Philips 
Electronics, Amsterdam, The Netherlands) examining several 
different levels of each sample.
Statistical analysis
All results were expressed as mean ±SD. A P-value of 0.05 was 
considered statistically significant. For the molecular data, sig-
nificance was evaluated using one- or two-way ANOVA followed 
by Student-Newman-Keuls post hoc tests, or t-tests as appro-
priate. For the baseline data and clinical characteristics, the 
continuous variables were first tested for normality using the 
Shapiro-Wilk test and then compared using the Student t-test 
or Mann-Whitney U test, accordingly. The categorical variables 
were compared using the Fisher’s exact test and ordinal vari-
ables using the Mann-Whitney U test. Statistical analysis was 
assessed using the Statistical Package for Social Sciences pro-
gram for Windows, version 25.0 (SPSS, Inc., Chicago, IL, USA).
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Results
Patients demographic and clinical data
The demographic and clinical data of patients studied are de-
scribed in Table 1 and the control patients in Table 2.
Histopathology
With H and E staining, cardiomyocytes of the control hearts 
showed regular organization. The nuclei had consistent elon-
gate shape and the myofibrils were compact (Figure 1A, 1B). 
Conversely, several cardiomyocytes from the failing hearts 
showed altered morphology. The nuclei were irregular in shape 
with bitten-like signs at one pole. Around these nuclei, mainly 
in proximity of the “bitten pole”, large areas of empty cyto-
plasm containing clumps of brown granules were frequently 
observed (Figure 1C, 1D).
Increased autophagy in heart failure
LC3-II positive vacuolar staining was observed in 8.7±1.2% of 
myocytes in heart failure samples, compared with 1.2±0.3% of 
control hearts. In line with this finding, LC3 cleavage assessed 
by western blot analysis was 3.5-fold greater in failing hearts as 
compared to control hearts (Figure 2A). This was also confirmed 
by LC3-II IHC (Figure 2B–2D). There were no significant differ-
ences in the proportion of LC3-II positive cells in hearts from 
patients with ischemic cardiomyopathy compared with those 
with idiopathic dilated cardiomyopathy. We observed a repeti-
tive progression of LC3-II staining, supporting the existence of 
multiple autophagy stages, exhibiting progressively severe mor-
phological alterations progressively ingravescent, until cardio-
myocytes cell death ensues. Indeed, the staining began at one 
cytoplasmic pole of the cardiomyocytes (Figure 3A, stage I) and 
extended to both poles (Figure 3B, stage II). Subsequently, the 





Figure 1.  H and E staining. (A, B) Control heart: the cardiomyocytes show regular organization both at lower (A) and higher (B) 
magnification. The nuclei have regular elongate shape (arrows) and the myofibrils are compact. (C, D) Failing heart: already 
at lower magnification (C) many cardiomyocytes shows altered morphology. The nuclei are irregular in shape and shows 
“bite-like” signs. Around these nuclei, the cytoplasm is devoid of organelles (asterisks) and there are always clumps of 
lipofuscin-like brown granules (white arrows). Scale bar: A and C=20 µm; B and D=5 µm.
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cytosol to more peripheral cytosolic areas. Despite the grossly 
normal appearance at the initial stages of the autophagic pro-
cess, the nuclei displayed features of focal damage in the form 
of single or multiple concavities, probably expression of local 
erosion or digestion (bite-like signs) (Figure 3C, stage III). In the 
later stages, the nucleus underwent progressive vacuolization 
and final disintegration. At this advanced step of the process, 
the combination of LC3-II and propidium iodide staining gave 
the affected nuclei a peculiar “strawberry-like” appearance 




























Figure 2.  (A) Western blotting analysis for LC3-I and LC3-II. Cleaved LC3 is present in failing hearts only. (B) Anti-LC3-II IHC in control 
hearts: the cardiomyocytes show faint staining in small cytoplasm areas. (C) In failing hearts, the cardiomyocytes appear 
more intensely stained; scale bar 100 µm. The optical density for LC3-II staining is resumed in (D); ** t-test P<0.000. 
LC3 – light-chain-3 protein; IHC – immunohistochemistry.
A B C D E F
Figure 3.  Representative progression of autophagy in failing heart. (A) Stage I: LC3-II staining (green) began at one cytoplasmic nuclear 
pole of the cardiomyocyte; N – nucleus, propidium iodide staining. (B) Stage II: the autophagy extended to both nuclear 
poles. The nuclei have normal appearance. (C) Stage III: the autophagy radiated to more peripheral cytosolic areas. The nuclei 
exhibit findings of focal compromise in form of single or multiple concavities (arrow) as “bite-like” signs. (D) Stage IV: in the 
later stages, the nucleus underwent progressive vacuolization and final disintegration. Cardiomyocytes with massive green 
staining in combination with the red staining of nucleus, assume a “strawberry-like” appearance. (E) Representative IHC 
for anti-LC3-II ABC-diaminobenzidine staining shows a massive presence of stained vacuoles (black arrow) that originated 
from a nuclear pole (white arrow), N – nucleus. (F) Representative H and E staining of later stages (III and IV) of autophagy 
progression. Unipolar and bipolar clustered granules of different size (arrows), the nuclei appear vacuolated and shows small 
bit signs. The cytoplasm is apparently empty (asterisks); white bar=5 µm; black bar=10 µm. LC3 – light-chain-3 protein; 
IHC – immunohistochemistry.
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corroborated by histologic evaluation of the failing hearts by 
H and E and anti-LC3-II ABC-diaminobenzidine staining (Figure 
3E, 3F). Likewise, the morphological changes in the autoph-
agic process observed by optical microscopy were also con-
firmed by examination of the same failing hearts by electron 
microscopy (Figure 4A–4F).
Co-localization of autophagy and apoptosis
To evaluate whether autophagy could be associated with apop-
tosis, we performed immunofluorescence with both LC3-II and 
TUNEL, counterstaining the DNA with Topro 3. Figure 5A–5C 
shows that LC3-II positive areas co-localize with TUNEL staining, 
suggesting that both autophagy and apoptosis occur simulta-
neously in the same dying cells. TUNEL fluorescent positivity 
was observed in vesicles seemingly originating from the nu-
cleus, which shows erosions with a typical bite-like appear-
ance. This finding suggests that DNA fragments were present 
in all vesicles. Since tissue sections were stained with Sudan 
black to eliminate the auto-fluorescence of lipofuscin, the ob-
served TUNEL positivity is a reliable apoptosis marker. In order 
to confirm the localization of TUNEL, we also performed IHC 
for C3. Intense anti-C3 staining was observed inside the cy-




Figure 4.  (A–F) Failing heart: representative electron microscopy pictures of cardiomyocytes alteration in advanced stages of damage. 
(A) Damaged cardiomyocytes sometime show nuclei with chromatin condensation, combined with invaginations of the 
nuclear envelope (arrows) that contain finely granular material cytoplasm without organelles. It is interesting to note the 
close similarity between this ultrastructural image and the nuclear concavities in Figure 3C; scale bar=2.5 µm. (B) The 
autophagy extends from the perinuclear areas to farther portion of cytosol. This is devoid of organelles and contains few 
small mitochondria and voluminous electron-dense material (probably lipofuscin and/or residue of autophagosomes) of 
variable size immersed in finely granular and faint electron-dense matrix. The myofibrils are isolated (arrow) and shown 
sign of disorganization; scale bar=3 µm. (C) Dilated vesicles of variable size containing mitochondria (arrows), and/or other 
unrecognizable residues were commonly observed; scale bar 1 µm. (D) At later stages the nucleus is fragmented, chromatin 
is condensed and marginated. Large cytoplasmic area devoid of organelles is evident (star); scale bar=5 µm. (E) The nuclear 
envelope is irregular with small interruptions (arrows) from which light-electron-dense nuclear material comes out (head 
arrows). Around the nucleus, there is evident a large area of cytoplasm devoid to organelles (asterisk); m – mitochondria; 
scale bar=1.5 µm. (F) At very advanced stage, nuclear content appears more electron-transparent. The cytoplasm is empty 
and very disorganized, many waste products are present (arrows) and myofibrils are isolate (asterisk); scale bar=2.5 µm; 
N – nucleus.
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undergoing the final stage of the autophagy process. Of note, 
these nuclei had one pole apparently regular in shape, where-
as the opposite pole appeared to be strongly damaged, as if 
it had been “eaten into” TUNEL and anti-C3 positive staining 
started to become evident at the periphery of the affected nu-
clei as well as in the vesicles, which appeared to be detached 
from the same nuclei and accumulate in the surrounding cy-
tosolic areas (Figure 5D, 5E). Occasionally, the nuclei of cardiac 
cells from failing hearts exhibited homogenously intense anti-
C3 staining. For unclear reasons, such nuclei did not present 
evident erosions (“bite-like” signs), perhaps because they 
were not included in the section plan, and/or stained vesicles 
in the perinuclear cytoplasm (Figure 5F). Anti-C3 staining was 
seldom observed in cells other than myocytes from the failing 
hearts (Figure 5G).
Autophagy was also associated with features of oncosis 
and necroptosis
To test whether late stage cells from heart failure samples could 
jointly exhibit features of autophagy and oncosis, we stained 
the cells with LC3-II and with antibodies recognizing comple-
ment C9. Figure 6 portrays a myocyte showing co-localization 
of LC3-II and C9 staining. It should be noted that while the 
LC3-II staining was vesicle-based, the C9 staining was evenly 
spread throughout the cell. This would suggest that the acti-
vation of the oncotic process takes place simultaneously all 
over the cell.
To corroborate these observation, we also evaluated by IHC in 
serial sections of heart failure hearts and control hearts, the ex-
pression of the necroptosis markers RIP1 and RIP3. Failing hearts 
A B C
D E F G
Figure 5.  Co-localization of autophagy and apoptosis. (A–C) LC3 positive areas co-localize with the TUNEL, suggesting that both 
autophagy and apoptosis are present simultaneously in damaged cells. The sections were stained with Sudan black to 
delete the auto-fluorescence of lipofuscin. The nuclei are in blue. (D–G) Representative progression of apoptosis (ABC-
diaminobenzidine IHC for active-C3) in failing heart. (D) the nuclear rim appears to be slightly irregular and a slight staining 
is observed on the inner surface of the nuclear envelope (asterisk). At the nuclear poles there are numerous large vesicles 
with pale staining(arrow). (E) In the later stage of autophagic alteration, the vesicles (arrows) seem to originate from 
nucleus, are small and show a more intense staining. The nuclear pole from which the vesicles seem to originate appears 
truncated. Inside the IHC staining is moderate (asterisks). (F) Intense anti-C3 stained nuclei of cardiomyocytes from heart 
failure patients. These nuclei did not show “bite signs”, or cytoplasmic vesicles. (G) Non-cardiomyocytes cell nuclei (arrow) 
near at vessel (asterisk) were sometime seen in heart failure patients. Scale bar=10 µm. IHC – immunohistochemistry; 
C3 – cleaved-caspase-3.
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showed a significant increase in RIP1 positive staining. Almost 
all cardiomyocytes were intensely and diffusely stained, al-
though some cells showed a more intense positivity. Conversely, 
control hearts showed only faint and very scarce staining. Only 
a few cells presented with weak positivity in small areas of 
the cytosol (Figure 7A–7C). Likewise, RIP3 positive staining in-
creased significantly in the failing hearts and was seen to co-
localize with RIP1 labeling in the positive myocytes. Such co-
localization was also observed in the few RIP1/RIP3 positive 
cardiac cells from the control hearts (Figure 7D–7F).
Finally, in order to evaluate potential inflammatory alterations 
in cardiomyocytes, we assessed the expression level of NF-kB 
in cardiac sections from heart failure patients (Figure 8A–8C). 
Intensely positive staining for NF-kB was observed not only 
in the cytosol, but also in the nucleus of several cardiomyo-
cytes from failing heart samples (Figure 8A, 8C). Sometimes, 
the NF-kB positive nuclei showed large “bite-like” erosions at 
pole extremities (Figure 8A inserts). Conversely, NF-kB staining 
was sporadic and faint in cardiac myocytes from control heart 
samples. Such positive staining was almost exclusively seen in 
A B
Figure 6.  Co-localization of autophagy (A) and oncosis (B). Representative pictures of cell showing generalized cytoplasmic LC3-II 
staining also show intense C9 reactivity. However, it should be noted that while the LC3-II staining were concentrated in 
separated oval areas with different intensity, the C9 staining is evenly spread throughout the cell. Nuclei are in red. Scale 








































Figure 7.  Serial sections with anti-RIP1 and anti-RIP3 immunostaining. (A–C) RIP1 in failing heart (A) shows strong and diffuse staining. 
Some cardiomyocytes are very strongly stained (arrows). Control heart (B) shows faint and very scarce staining. Only small 
cytoplasmic areas are moderately stained. The optical density for RIP1 staining is resumed in (C). (D–F) RIP3 in failing heart 
(D): the cardiomyocytes that appear strongly RIP3-stained (arrows) correspond those strongly RIP1 stained. Control heart 
(B), the cardiomyocytes shows moderate staining in small cytoplasm areas that overlap those stained with RIP1. The optical 
density for RIP3 staining is resumed in (F). Scale bars=100 µm, ** t-test, P<0.000. RIP1 – receptor interacting protein kinase 1; 
RIP3 – receptor interacting protein kinase 3.
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small areas of the cytosol (Figure 8B and insert), while nuclei 
were seldom immunostained (Figure 8C). The optical density 
for NF-kB staining is presented in Figure 8D.
Discussion
The main aim of this study was to assess the status and pro-
gression of autophagy and oncosis/necroptosis, in the ex vivo 
heart of patients with intractable heart failure. Indeed, a char-
acteristic feature of heart failure is progressive loss of cardiac 
myocytes and development of cardiac dysfunction. So, the 
identification of the main mechanisms leading to progressive 
myocyte cell death could provide a valuable base for the de-
velopment of clinically useful therapeutic intervention.
Autophagy is an intracellular lysosome-mediated catabolic 
mechanism responsible for the bulk degradation and recycling 
of damaged or dysfunctional cytoplasmic components and or-
ganelles [29]. Although autophagy is fundamental for cellular 
homeostasis, higher autophagy rates can result in cell death 
Figure 8.  NF-kB immunostaining. (A) Cardiomyocytes in failing heart had intense NF-kB staining distributed not only inside large 
cytoplasm areas, but also in a large proportion of nuclei. The cytoplasm appears empty with a lot of debris product (arrows, 
right insert). The nuclei sometimes showed large “bite-like” signs at pole extremities (arrow in left insert). Conversely (B, and 
insert), NF-kB was faintly expressed inside the small cytoplasmic areas of control heart samples. The quantitative data of 
stained nuclei are shows in (C). The optical density for NF-kB staining is resumed in (D). Original magnification 200×; scale 
bar 30 μm; ** P<0.01. NF-kB – nuclear factor kappa-light-chain-enhancer of activated B cells.
**
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secondary to cell cannibalization. Indeed, autophagy is asso-
ciated with many pathological states such as cancer, neurode-
generative disorders, myopathies, and cardiomyopathies [27].
Detection of LC3-positive structures, either by immunostaining 
of endogenous LC3 or localization of transfected GFP-LC3, is 
the most commonly used method to detect autophagosomes 
by light microscopy. However, electron microscopy analysis is 
required to demonstrate the direct sequestration of LC3 ag-
gregates by autophagosomes [30,31].
Our results showed that autophagy, unlike apoptotic cell death, 
was largely present in failing heart cardiomyocytes. The early 
detection by electron microscopy of numerous autophago-
somes in cardiomyocytes from heart failure patients indicated 
that autophagocytosis was a relevant process driving cardio-
myocytes to death.
Furthermore, our study has shown that the progression of au-
tophagy occurs according to a set sequence, traversing 4 pro-
gressive phases (from I to IV). Our findings indicate that the 
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nucleus is an early autophagic target and develops typical ero-
sions with a bite-like appearance. Remarkably, in the most ad-
vanced stages of the process, the autophagic vacuoles, in ad-
dition to LC3 positivity, develop TUNEL positivity, suggesting 
that their content is represented by DNA fragments eaten away 
from the nucleus. Myocytes exhibiting combined LC3 and TUNEL 
positive staining acquire a peculiar “strawberry-like appear-
ance”, which is morphologically original and has never been 
previously described. In addition, our data demonstrated that 
autophagy was accompanied by oncosis, especially in the ter-
minal phases of the autophagic process. The autophagic myo-
cytes undergoing oncosis did not show dramatic cytoplasmic 
and/or nuclear abnormalities, which suggests an early stage 
of the process.
Programmed necrosis, also called necroptosis, is a caspase-
independent RIP3-mediated form of cell death, which has re-
cently been identified as a novel mechanism of cell death 
implicated in the pathogenesis of pathological conditions af-
fecting different organs and apparatuses [32]. Our findings re-
vealed enhanced RIP3 expression in cardiac cells from the hu-
man failing heart. This is in line with published data showing 
that RIP3 overexpression in the mouse heart can induce myo-
cardial infarction, while the formation of RIP1/RIP3 complex 
can drive cardiomyocytes to necrosis [33].
Activation of RIP3 is regulated by the kinase RIP1 [34], a key 
player in the modulation of cell fate in response to different 
stimuli [35]. We documented increased expression of the pro-
necroptotic proteins RIP3 and RIP1 in the human heart under-
going end-stage heart failure, which indicates the occurrence 
of both necroptosis activation and execution. Since RIP3/RIP1 
overexpression was seen to frequently occur in LC3 positive 
myocytes, and only occasionally in LC3 negative cells, we pos-
tulated that necroptosis was chiefly triggered after initiation 
of autophagy. Our findings corroborated the results of a recent 
study that showed that human hearts with chronic heart failure 
secondary to myocardial infarction or dilated cardiomyopathy 
were positive for markers of necroptosis [36]. Although RIP1 
is known to mediate cell death in response to DNA damage, it 
is also crucial for cell survival through activation of the NF-kB 
pathway [37]. Indeed, the anti-apoptotic activity of NF-kB may 
avoid unnecessary and/or redundant cell death in response to 
apoptotic stimuli such as TNF-a activation [24]. Accordingly, 
our findings documented that myocytes overexpressing both 
RIP1 and nuclear NF-kB, were TUNEL and RIP3 negative, sug-
gesting that the RIP1/NF-kB pathway serves as an efficient 
survival pathway in the failing human heart.
Although rare in normal human myocardium (0.01–0.001%), 
the occurrence of apoptosis in human myocytes from failing 
hearts appears to be slightly higher (0.12–0.70%) [38]. Apoptosis 
has also been shown to be involved in acute and chronic loss 
of cardiomyocytes occurring in myocardial infarction, ischemic 
heart disease, reperfusion injury, and various forms of cardio-
myopathy [39,40]. More recent findings have demonstrated that 
in human and monkey failing hearts, the rate of apoptosis in 
non-cardiomyocytes was higher than cardiomyocytes [41]. In 
line with such studies, we observed a low expression of pro-
apoptotic markers in both cardiomyocytes and non-cardio-
myocytes from failing hearts. Taken together, our data sug-
gest that apoptosis, in comparison to autophagy and oncosis/
necroptosis, is neither the earliest nor the main type of cell 
death detected in cardiomyocytes from heart failure patients.
In this work, we predominantly focused on the morphological 
aspects of cell death occurring in the setting of advanced heart 
failure in humans. To this end, we relied almost exclusively 
on IHC, whose limitations represent the major weakness of 
the current work. Indeed, the soundness of IHC is operator-
dependent, requiring rigor of execution (to prevent technical 
errors potentially leading to misinterpretation) and analytical 
skills (to minimize the risk of bias). The longstanding experi-
ence of the operators in the specific field of IHC should vouch 
for the scientific accuracy of the data presented in our work.
Conclusions
In conclusion, our study showed for the first time that in the 
failing human heart autophagy precedes and sets the stage 
for the occurrence of apoptosis, oncosis, and necroptosis, 
which only rarely start independently from autophagy. Hence, 
autophagy seems to be a primary driving force leading to the 
progressive cardiomyocyte cell loss observed in end-stage 
heart failure.
Abbreviations
C3 – cleaved-caspase 3; C9 – complement factor 9; LC3 – 
microtubule associated protein light chain 3; RIP1 – receptor-
interacting serine/threonine-protein kinase 1; RIP3 – receptor-
interacting serine/threonine-protein kinase 3; NF-kB: nuclear 
factor kappa-light-chain-enhancer of activated B cells; TUNEL 
– terminal deoxynucleotidyl transferase – mediated deoxyuri-
dine triphosphate nick end labeling.
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